[Application of multiplex ligation-dependent probe amplification to diagnosis and prenatal diagnosis of common aneuploidies]

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011 Apr;28(2):212-6. doi: 10.3760/cma.j.issn.1003-9406.2011.02.020.
[Article in Chinese]

Abstract

Objective: To investigate the application value of the multiplex ligation-dependent probe amplification (MLPA) technique in diagnosis and prenatal diagnosis of chromosomes 13, 18, 21, X and Y aneuploidy.

Methods: Forty-four cases including 30 peripheral blood samples, 10 fetal cord blood samples, and 4 amniotic fluid samples were collected in this study. DNA was isolated from the samples and detected by MLPA, followed by analyzing in ABI310 Genetic Analyzer. Analysis of copy number changes for chromosomes 13, 18, 21, X and Y was carried out with RH-MLPA-analysis software. The routine karyotype analyses were also done for all the samples.

Results: Of 44 samples, the results of 42 by MLPA method was consistent with that by chromosome karyotyping. Only one case with trisomy 21 chimerism was failed to reach conclusion. In addition, one case of mark chromosome segment was identified as Y-chromosome segment by MLPA, while karyotyping failed to make judgment. The accurate rate of MLPA was 97.7% (43/44).

Conclusion: The MLPA technique can simultaneously detect dozens of different target sequences and their copy number changes in a single reaction. It showed high specificity, good reproducibility, was fast and high-throughput. The MLPA technique can be applied to diagnosis and prenatal diagnosis of the common chromosomal aneuploidy.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amniotic Fluid / chemistry
  • Aneuploidy*
  • Chromosomes, Human, Pair 13
  • DNA / genetics
  • DNA / isolation & purification
  • DNA Copy Number Variations
  • Down Syndrome / diagnosis
  • Down Syndrome / genetics
  • Female
  • Fetal Blood / chemistry
  • Humans
  • Nucleic Acid Amplification Techniques / methods*
  • Pregnancy
  • Prenatal Diagnosis / methods*
  • Sensitivity and Specificity

Substances

  • DNA